• Søndre Skovvej 15, Forskningens Hus

    9000 Aalborg

    Denmark

Organization profile

Organisation profile

The main focus for Aalborg Thrombosis Research Unit (ATRU) is to study basic and clinical aspects of thrombosis and vascular disease and to develop new diagnostic and therapeutic tools.

ATRU is an inter-disciplinary, international center with a scientific staff working within medicine, epidemiology, statistics, engineering and economics. The center has a large group of PhD students. The majority of researchers come from the Aalborg area. In 2013 Professor Gregory Y.H. Lip was appointed adjunct Professor at ATRU and the same year honored as honorary doctor at Aalborg University.

ATRU was established as a Research Center in 2012 with support from the Obel Family Foundation and The Northern Region of Denmark. ATRU is headed by associate professor Torben Bjerregaard Larsen.

The center supports networking and collaboration across clinical departments and units. The center covers all aspects of cardiovascular research, including research in epidemiology, statistics, and pharmacovigilance

 

Researchers

Gregory Y.H. Lip

Torben Bjerregaard Larsen

Lars Hvilsted Rasmussen

Peter Brønnum Nielsen

Flemming Skjøth

Jette Kjældgaard

Mette Søgaard

Frede Aakmann Tøgersen

Line Melgaard

Thure Filskov Overvad

Anette Arbjerg Højen

 

PhD Students

Anne Sig Vestergaard

Mia Vicky Fangel

Ida Ehlers Albertsen 

 

Former PhD Students

Line Melgaard (2016)

Thure Filskov Overvad (2016)

Søren Due Andersen (2016)

Henrik Vadmann (2016)

Anette Arbjerg Højen (2016)

 

 

Anders Gorst Rasmussen Former employee

 

Fingerprint The fingerprint consists of concepts related to the research profile of the unit and associated persons. It is updated automatically, when new content is added.

Atrial Fibrillation Medicine & Life Sciences
Stroke Medicine & Life Sciences
Anticoagulants Medicine & Life Sciences
Warfarin Medicine & Life Sciences
Hemorrhage Medicine & Life Sciences
Registries Medicine & Life Sciences
Cohort Studies Medicine & Life Sciences
Vitamin K Medicine & Life Sciences

Network Dive into details by clicking on the dots.

Research Output 2012 2019

1 Citation (Scopus)

ABC (Atrial fibrillation Better Care) pathway and healthcare costs in atrial fibrillation. The ATHERO-AF study

Pastori, D., Farcomeni, A., Pignatelli, P., Violi, F. & Lip, G. Y., 16 Jan 2019, In : The American Journal of Medicine.

Research output: Contribution to journalJournal articleResearchpeer-review

Health Care Costs
Atrial Fibrillation
Costs and Cost Analysis
Stroke
Vitamin K

Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities

Chao, T-F., Lip, G. Y. H., Lin, Y-J., Chang, S-L., Lo, L-W., Hu, Y-F., Tuan, T-C., Liao, J-N., Chung, F-P., Chen, T-J. & Chen, S-A., 2 Jan 2019, In : European Heart Journal.

Research output: Contribution to journalJournal articleResearchpeer-review

Anticoagulants
Atrial Fibrillation
Comorbidity
Stroke
Vascular Diseases

Activities 2015 2016

  • 7 Talks and presentations in private or public companies
  • 5 Conference presentations

Assessment of a stroke risk stratification scheme in a heart failure population in sinus rhythm

Line Melgaard (Lecturer)
30 Aug 2015

Activity: Talks and presentationsTalks and presentations in private or public companies

Beta-blockers in atrial fibrillation patients with or without heart failure: insights from a nationwide cohort

Peter Brønnum Nielsen (Speaker)
30 Aug 2015

Activity: Talks and presentationsTalks and presentations in private or public companies

CHA2DS2-VASc Score=1: No Treatment, Aspirin or Oral Anticoagulation?

Peter Brønnum Nielsen (Lecturer)
10 Jun 2016

Activity: Talks and presentationsConference presentations